bullish

Kansai Nerolac - Weakest Among Peers; Pain Seems Priced In

180 Views07 Jun 2022 07:29
Broker
Kansai Nerolac’s (KNPL) standalone revenue, at 6.2% YoY (INR14.1bn, 3-year CAGR: 8%), was largely in line. In decorative segment, volume declined 7-8% while value remained flat YoY in Q4;
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
HDFC Securities
External broker reports(aggregated public sources)
HDFC Securities
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Kansai Nerolac - Weakest Among Peers; Pain Seems Priced In
    07 Jun 2022
x